S SCITARIS BIOPHARMA STRATEGY
LIVE

Serial Number

79330088

Owner

Scitaris GmbH

Attorney

Frank D Taff

Filing Date

Jul 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

S SCITARIS BIOPHARMA STRATEGY Trademark

Serial Number: 79330088 • Registration: 6805709

S SCITARIS BIOPHARMA STRATEGY is a trademark filed by Scitaris GmbH on July 5, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Scitaris GmbH (2 trademarks)

Lennestr. 9

Entity Type: 16

Scitaris GmbH & Co. KG

Lennestr. 9

Entity Type: 98

Trademark Details

Filing Date

July 5, 2021

Registration Date

August 2, 2022

Published for Opposition

May 17, 2022

Goods & Services

Scientific and technological services, namely, research and design in the field of pharmaceuticals; medical device design services; product development; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; medical and pharmacological research services; quality control for others in the field of pharmaeeuticals; authentication services being inspection of pharmaceuticals

Advertising; business management; business administration

Medical services; pharmacy advice; medical consultancy and information services relating to medical products

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 7, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 10, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 10, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 2, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 2, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2022 PUBO
NOTIFICATION PROCESSED BY IB
May 16, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 27, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2022 NONP
REFUSAL PROCESSED BY IB
Apr 18, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 26, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 25, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 30, 2021 REPR